Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research focused on Multiple sclerosis and Natalizumab, with related work in Magnetic resonance imaging, Discontinuation, Myelitis. Notable publications include 'Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients', 'Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome', and 'Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study'.
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis
Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome
MSCopilot: New smartphone-based digital biomarkers correlate with Expanded Disability Status Scale scores in people with Multiple Sclerosis
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions
Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders
Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study
MSCopilot, a new multiple sclerosis self‐assessment digital solution: results of a comparative study versus standard tests
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France
Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis
MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study
Risk of relapse after natalizumab withdrawal